{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:16:42Z","timestamp":1758709002288,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T00:00:00Z","timestamp":1539993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/PR8275\/BID\/7\/455\/2013"],"award-info":[{"award-number":["BT\/PR8275\/BID\/7\/455\/2013"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Model"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00894-018-3849-7","type":"journal-article","created":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T15:28:44Z","timestamp":1540049324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pharmacophore and molecular dynamics based activity profiling of natural products for kinases involved in lung cancer"],"prefix":"10.1007","volume":"24","author":[{"given":"Pankaj Kumar","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Om","family":"Silakari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,20]]},"reference":[{"key":"3849_CR1","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1016\/j.ddtec.2010.11.006","volume":"7","author":"D Schuster","year":"2011","unstructured":"Schuster D (2011) 3D pharmacophores as tools for activity profiling. Drug Discov Today Technol 7:e205\u2013e211","journal-title":"Drug Discov Today Technol"},{"key":"3849_CR2","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s10822-006-9066-y","volume":"20","author":"TM Steindl","year":"2006","unstructured":"Steindl TM, Schuster D, Wolber G, Laggner C, Langer T (2006) High-throughput structure-based pharmacophore modelling as a basis for successful parallel virtual screening. J Comput Aided Mol Des 20:703\u2013715","journal-title":"J Comput Aided Mol Des"},{"key":"3849_CR3","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1021\/ci300083r","volume":"52","author":"J Meslamani","year":"2012","unstructured":"Meslamani J, Li J, Sutter J, Stevens A, Bertrand H-O, Rognan D (2012) Protein\u2013ligand-based pharmacophores: generation and utility assessment in computational ligand profiling. J Chem Inf Model 52:943\u2013955","journal-title":"J Chem Inf Model"},{"key":"3849_CR4","first-page":"128","volume":"1866","author":"PK Singh","year":"2016","unstructured":"Singh PK, Singh H, Silakari O (2016) Kinases inhibitors in lung cancer: from benchside to bedside. Biochim Biophys Acta 1866:128\u2013140","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"3849_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1146\/annurev-cancerbio-050216-122044","volume":"1","author":"Ibiayi Dagogo-Jack","year":"2017","unstructured":"Dagogo-Jack I, Engelman JA, Shaw AT (2016) Overcoming on-target resistance to tyrosine kinase inhibitors in lung cancer. Annu Rev Cancer Biol 1:257\u2013274","journal-title":"Annual Review of Cancer Biology"},{"key":"3849_CR6","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1021\/cb500870a","volume":"10","author":"M Tong","year":"2014","unstructured":"Tong M, Seeliger MA (2014) Targeting conformational plasticity of protein kinases. ACS Chem Biol 10:190\u2013200","journal-title":"ACS Chem Biol"},{"key":"3849_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.lfs.2017.08.001","volume":"186","author":"PK Singh","year":"2017","unstructured":"Singh PK, Silakari O (2017) Chemotherapeutics-resistance \u201carms\u201d race: an update on mechanisms involved in resistance limiting Egfr inhibitors in lung cancer. Life Sci 186:25\u201332","journal-title":"Life Sci"},{"key":"3849_CR8","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMoa1408440","volume":"371","author":"BJ Solomon","year":"2014","unstructured":"Solomon BJ, Mok T, Kim D-W, Wu Y-L, Nakagawa K, Mekhail T, Felip E, Cappuzzo F, Paolini J, Usari T (2014) First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med 371:2167\u20132177","journal-title":"N Engl J Med"},{"key":"3849_CR9","first-page":"189","volume":"12","author":"AD Kinghorn","year":"2009","unstructured":"Kinghorn AD, Chin Y-W, Swanson SM (2009) Discovery of natural product anticancer agents from biodiverse organisms. Curr Opin Drug Discov Dev 12:189","journal-title":"Curr Opin Drug Discov Dev"},{"key":"3849_CR10","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/ptr.5669","volume":"30","author":"S Safe","year":"2016","unstructured":"Safe S, Kasiappan R (2016) Natural products as mechanism-based anticancer agents: Sp transcription factors as targets. Phytother Res 30:1723\u20131732","journal-title":"Phytother Res"},{"key":"3849_CR11","unstructured":"Dassault Syst\u00e8mes BIOVIA (2015) Discovery studio modeling environment, Release 4. Dassault Systemes, San Diego, CA"},{"key":"3849_CR12","first-page":"171","volume":"2","author":"H Li","year":"2000","unstructured":"Li H, Sutter J, Hoffmann R (2000) HypoGen: an automated system for generating 3D predictive pharmacophore models. Pharmaco Percept Dev Use Drug Design 2:171","journal-title":"Pharmaco Percept Dev Use Drug Design"},{"key":"3849_CR13","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1021\/ci900254b","volume":"49","author":"S Brogi","year":"2009","unstructured":"Brogi S, Kladi M, Vagias C, Papazafiri P, Roussis V, Tafi A (2009) Pharmacophore modeling for qualitative prediction of antiestrogenic activity. J Chem Inf Model 49:2489\u20132497","journal-title":"J Chem Inf Model"},{"key":"3849_CR14","first-page":"591","volume":"75","author":"DB Rubin","year":"1980","unstructured":"Rubin DB (1980) Randomization analysis of experimental data: the fisher randomization test comment. J Am Stat Assoc 75:591\u2013593","journal-title":"J Am Stat Assoc"},{"key":"3849_CR15","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1021\/ci700024q","volume":"47","author":"J Kirchmair","year":"2007","unstructured":"Kirchmair J, Ristic S, Eder K, Markt P, Wolber G, Laggner C, Langer T (2007) Fast and efficient in silico 3D screening: toward maximum computational efficiency of pharmacophore-based and shape-based approaches. J Chem Inf Model 47:2182\u20132196","journal-title":"J Chem Inf Model"},{"key":"3849_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/prot.10270","volume":"50","author":"JL Jenkins","year":"2003","unstructured":"Jenkins JL, Kao RY, Shapiro R (2003) Virtual screening to enrich hit lists from high-throughput screening: a case study on small-molecule inhibitors of angiogenin. Prot Struct Funct Bioinform 50:81\u201393","journal-title":"Prot Struct Funct Bioinform"},{"key":"3849_CR17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29\u201336","journal-title":"Radiology"},{"key":"3849_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jmgm.2013.12.008","volume":"49","author":"S Kalva","year":"2014","unstructured":"Kalva S, Singam EA, Rajapandian V, Saleena LM, Subramanian V (2014) Discovery of potent inhibitor for matrix metalloproteinase-9 by pharmacophore based modeling and dynamics simulation studies. J Mol Graph Model 49:25\u201337","journal-title":"J Mol Graph Model"},{"key":"3849_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","volume":"45","author":"JJ Irwin","year":"2005","unstructured":"Irwin JJ, Shoichet BK (2005) ZINC\u2212 a free database of commercially available compounds for virtual screening. J Chem Inf Model 45:177\u2013182","journal-title":"J Chem Inf Model"},{"key":"3849_CR20","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1002\/jcc.10306","volume":"24","author":"G Wu","year":"2003","unstructured":"Wu G, Robertson DH, Brooks CL, Vieth M (2003) Detailed analysis of grid-based molecular docking: a case study of CDOCKER\u2014A CHARMm-based MD docking algorithm. J Comput Chem 24:1549\u20131562","journal-title":"J Comput Chem"},{"key":"3849_CR21","doi-asserted-by":"publisher","first-page":"D233","DOI":"10.1093\/nar\/gki057","volume":"33","author":"N Deshpande","year":"2005","unstructured":"Deshpande N, Addess KJ, Bluhm WF, Merino-Ott JC, Townsend-Merino W, Zhang Q, Knezevich C, Xie L, Chen L, Feng Z (2005) The RCSB protein data Bank: a redesigned query system and relational database based on the mmCIF schema. Nucleic Acids Res 33:D233\u2013D237","journal-title":"Nucleic Acids Res"},{"key":"3849_CR22","unstructured":"Singh PK, Silakari O (2018) In-silico guided development of imine based inhibitors for resistance-deriving kinases. J Biomol Struct Dyn:1\u201321"},{"key":"3849_CR23","doi-asserted-by":"publisher","first-page":"469","DOI":"10.4155\/fmc-2016-0234","volume":"9","author":"PK Singh","year":"2017","unstructured":"Singh PK, Silakari O (2017) Novel EGFR (T790M)-cMET dual inhibitors: putative therapeutic agents for non-small-cell lung cancer. Future Med Chem 9:469\u2013483","journal-title":"Future Med Chem"},{"key":"3849_CR24","unstructured":"Maestro (2018) Schr\u00f6dinger Release 2018-3, LLC, New York, NY"},{"key":"3849_CR25","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.bioorg.2018.04.001","volume":"79","author":"PK Singh","year":"2018","unstructured":"Singh PK, Silakari O (2018) Molecular dynamics guided development of indole based dual inhibitors of EGFR (T790M) and c-MET. Bioorg Chem 79:163\u2013170","journal-title":"Bioorg Chem"}],"container-title":["Journal of Molecular Modeling"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00894-018-3849-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-018-3849-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00894-018-3849-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T19:17:51Z","timestamp":1571512671000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00894-018-3849-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,20]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["3849"],"URL":"https:\/\/doi.org\/10.1007\/s00894-018-3849-7","relation":{},"ISSN":["1610-2940","0948-5023"],"issn-type":[{"type":"print","value":"1610-2940"},{"type":"electronic","value":"0948-5023"}],"subject":[],"published":{"date-parts":[[2018,10,20]]},"assertion":[{"value":"10 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"318"}}